Factors associated with treatment failure for chemotherapy-induced nausea and vomiting (CINV) among breast cancer patients receiving adjuvant chemotherapy

被引：0
|
作者：
Yeo, Winnie
Ngai, Nicole
Yeo, Horatio
Lai, Dong
Pang, Elizabeth
Kwok, Carol
Lau, Thomas
Mo, Frankie
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-11-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-11-12
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A nomogram to individually predict the presence of chemotherapy-induced nausea and vomiting (CINV) in cancer patients
    Hu, Zhihuang
    Liang, Wenhua
    Zhang, Li
    Ma, Yuxiang
    Chen, Likun
    Huang, Yan
    Zhao, Hongyun
    Zhou, Ting
    Fang, Wenfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Chemotherapy-induced nausea and vomiting in breast cancer patients: effectiveness of antiemetic treatment
    Chiva, E. D.
    Alfaro, M. J. D. M.
    Martinez, E. G.
    Sansalvador, M. H.
    Sebastia, M. R. G.
    Martinez, B. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 908 - 909
  • [23] Rolapitant for control of chemotherapy-induced nausea and vomiting (CINV) in patients with gynecologic cancer.
    Rapoport, Bernardo Leon
    Schwartzberg, Lee Steven
    Arora, Sujata
    Powers, Daniel
    Jordan, Karin
    Navari, Rudolph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26)
  • [24] Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy
    Gao, Ai
    Guan, Shasha
    Sun, Yinjuan
    Wang, Lingling
    Meng, Fanlu
    Liu, Xia
    Gu, Liyan
    Li, Guo
    Zhong, Diansheng
    Zhang, Linlin
    BMC CANCER, 2023, 23 (01)
  • [25] Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy
    Ai Gao
    Shasha Guan
    Yinjuan Sun
    Lingling Wang
    Fanlu Meng
    Xia Liu
    Liyan Gu
    Guo Li
    Diansheng Zhong
    Linlin Zhang
    BMC Cancer, 23
  • [26] The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.
    Navari, Rudolph M.
    Nagy, Cindy K.
    Gray, Sarah E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Evaluation of potential factors related to chemotherapy-induced nausea and vomiting (CINV) among Chinese breast cancer patients: individual patient data analysis
    Yeo, W.
    Yeo, H.
    Lai, K.
    Pang, E.
    Mo, F.
    BREAST, 2023, 68 : S114 - S114
  • [28] Rolapitant for the prevention of chemotherapy-induced nausea and vomiting in breast cancer patients receiving multiple cycles of emetogenic chemotherapy
    Schwartzberg, L.
    Navari, R.
    Arora, S.
    Powers, D.
    Jordan, K.
    Rapoport, B.
    CANCER RESEARCH, 2017, 77
  • [29] Efficacy of antiemetic regimens for prevention and treatment of chemotherapy-induced nausea and vomiting in patients of breast cancer receiving highly emetogenic chemotherapy
    Vij, Soumya
    Dhasmana, Dilip Chander
    Bala, Suman
    Verma, Sanjiv Kumar
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (06) : 819 - 824
  • [30] Identifying predictive factors of chemotherapy-induced nausea and vomiting (CINV): a novel approach
    Scotte, F.
    ANNALS OF ONCOLOGY, 2017, 28 (06) : 1165 - 1167
12345